Filing Details
- Accession Number:
- 0001225208-13-017276
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-05 16:08:13
- Reporting Period:
- 2013-08-01
- Filing Date:
- 2013-08-05
- Accepted Time:
- 2013-08-05 16:08:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1335303 | L Peter Wehrly | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-08-01 | 8,286 | $39.18 | 33,275 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-08-01 | 8,286 | $62.92 | 24,989 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-01 | 8,286 | $0.00 | 8,286 | $39.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,857 | 2020-11-30 | No | 4 | M | Direct |
Footnotes
- Includes 4 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- Shares sold pursuant to an existing Rule 10b5-1 trading plan.
- Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.